SteelPeak Wealth LLC Purchases New Position in Corteva, Inc. $CTVA

Key Points

• SteelPeak Wealth LLC opened a new position in Corteva in Q4, buying 58,055 shares valued at about $3.89 million, while institutional investors collectively own roughly 81.54% of the company.
• Insider Brian Titus sold 8,311 shares on Feb. 20 at an average price of $76.55—reducing his stake by 50.67%—and company insiders now own just 0.14% of Corteva.
• Corteva reported Q results with EPS of $0.22 (in line with estimates) and revenue of $3.91 billion (below consensus), set FY2026 guidance of 3.450–3.700 EPS, and carries a MarketBeat consensus price target of about $83.19 ("Moderate Buy").

SteelPeak Wealth LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 58,055 shares of the company's stock, valued at approximately $3,891,000.

A number of other hedge funds have also recently added to or reduced their stakes in CTVA. Chilton Capital Management LLC increased its holdings in Corteva by 18.1% in the 3rd quarter. Chilton Capital Management LLC now owns 445,350 shares of the company's stock worth $30,119,000 after purchasing an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC bought a new position in Corteva in the third quarter valued at about $4,284,000. Truist Financial Corp boosted its stake in shares of Corteva by 4.5% during the third quarter. Truist Financial Corp now owns 321,913 shares of the company's stock valued at $21,771,000 after purchasing an additional 13,910 shares in the last quarter. New York State Teachers Retirement System grew its holdings in shares of Corteva by 4.5% during the third quarter. New York State Teachers Retirement System now owns 551,389 shares of the company's stock worth $37,290,000 after purchasing an additional 23,548 shares during the last quarter. Finally, Alberta Investment Management Corp bought a new stake in shares of Corteva during the third quarter worth about $5,018,000. Institutional investors and hedge funds own 81.54% of the company's stock.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company's stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.14% of the company's stock.

Corteva Stock Performance

Shares of CTVA stock opened at $85.50 on Friday. The stock has a market capitalization of $57.40 billion, a PE ratio of 54.12, a PEG ratio of 2.92 and a beta of 0.68. The business's 50 day simple moving average is $77.62 and its 200 day simple moving average is $70.10. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $53.40 and a one year high of $85.56.

Corteva (NYSE:CTVA - Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the previous year, the company earned $0.32 EPS. The company's revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were issued a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a yield of 0.8%. Corteva's payout ratio is presently 45.57%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Corteva from $85.00 to $90.00 and gave the company a "buy" rating in a report on Thursday, February 5th. CICC Research upped their price target on shares of Corteva from $70.00 to $80.00 and gave the company an "outperform" rating in a research report on Wednesday, February 11th. Wolfe Research raised their price target on shares of Corteva from $81.00 to $86.00 and gave the company an "outperform" rating in a research note on Thursday, February 5th. Wells Fargo & Company lifted their price target on shares of Corteva from $77.00 to $85.00 and gave the stock an "overweight" rating in a report on Thursday, February 5th. Finally, Zacks Research cut shares of Corteva from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 20th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Corteva currently has an average rating of "Moderate Buy" and a consensus price target of $83.19.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.